Stockreport

FDA accepts Coherus Bio's refiled application for Neulasta biosimilar, action date November 3 [Seeking Alpha]

Coherus BioSciences, Inc.  (CHRS) 
Last coherus biosciences, inc. earnings: 2/27 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.coherus.com
PDF FDA accepts Coherus Bio's refiled application for Neulasta biosimilar, action date November 3The FDAaccepts for review Coherus BioSciences' (CHRS-0.6%) resubmitted marke [Read more]